MM
Publicaties op Oncologisch.com
Upfront Modified FOLFOXIRI Plus Panitumumab for RAS/BRAF Wild-Type Metastatic Colorectal Cancer: Final Results of the...
The relative dose intensity of eerstelijns FOLFOXIRI and FOLFOX/FOLFIRI both in combination with bevacizumab affects ...
Reactie op: herkadering van HER2 bij colorectaal carcinoom